Delayed hemolytic transfusion reaction with hyperhemolysis after first red blood cell transfusion in child with β-thalassemia: Challenges in treatment

Transfusion

Volumn 50, Issue 2, 2010, Pages 429-432

  Hannema, Sabine E ^a,b   Brand, Anneke ^a,b   Van Meurs, Alfred ^a,b   Smiers, Frans J ^a,b  

^a HAGA HOSPITAL   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; MELPHALAN; METHOTREXATE; PREDNISONE; RITUXIMAB; THYMOCYTE ANTIBODY; TREOSULFAN;

ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION REACTION; BONE DEVELOPMENT; CASE REPORT; CHILD; COOMBS TEST; DEVELOPMENTAL DISORDER; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; ERYTHROCYTE TRANSFUSION; FEMALE; GRAFT VERSUS HOST REACTION; GROWTH RETARDATION; HEMOLYSIS; HOMOZYGOSITY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; PRESCHOOL CHILD; SPLENECTOMY;

ANEMIA, HEMOLYTIC; ANEMIA, HEMOLYTIC, AUTOIMMUNE; BETA-THALASSEMIA; BONE MARROW TRANSPLANTATION; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; HYPERSPLENISM; IMMUNOSUPPRESSIVE AGENTS; INFANT; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PLATELET TRANSFUSION; SPLENECTOMY; TRANSPLANTATION, HOMOLOGOUS;

EID: 75749117123     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02399.x     Document Type: Article

References (15)

1. Garratty G. Severe reactions associated with transfusion of patients with sickle cell disease. Transfusion 1997 37 : 357 61.
2. Talano JA, Hillery CA, Gottschall JL, Baylerian DM, Scott JP. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease. Pediatrics 2003 111 : e661 e665.
3. Cox JV, Steane E, Cunningham G, Frenkel EP. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease. Arch Intern Med 1988 148 : 2485 9.
4. Kashyap R, Choudhry VP. Delayed hemolytic transfusion reaction in a thalassemic child. Indian J Pediatr 1994 61 : 726 8.
5. Sirchia G, Morelati F, Rebulla P. The sickle cell hemolytic transfusion reaction syndrome. Transfusion 1997 37 : 1098 9.
6. Treleaven JG, Win N. Hyperhaemolysis syndrome in a patient with myelofibrosis. Hematology 2004 9 : 147 9.
7. Darabi K, Dzik S. Hyperhemolysis syndrome in anemia of chronic disease. Transfusion 2005 45 : 1930 3.
8. Petz LD, Calhoun L, Shulman IA, Johnson C, Herron RM. The sickle cell hemolytic transfusion reaction syndrome. Transfusion 1997 37 : 382 92.
9. Rosse WF, Narla M, Petz LD, Steinberg MH. New views of sickle cell disease pathophysiology and treatment. Hematology Am Soc Hematol Educ Program. 2000 2 17.
10. Telen MJ, Harris G, Whitworth E. Caring for patients with sickle cell disease in North Carolina. N C Med J 1999 60 : 14 7.
11. Win N, Doughty H, Telfer P, Wild BJ, Pearson TC. Hyperhemolytic transfusion reaction in sickle cell disease. Transfusion 2001 41 : 323 8.
12. Cullis JO, Win N, Dudley JM, Kaye T. Post-transfusion hyperhaemolysis in a patient with sickle cell disease: use of steroids and intravenous immunoglobulin to prevent further red cell destruction. Vox Sang 1995 69 : 355 7.
13. Noizat-Pirenne F, Bachir D, Chadebech P, Michel M, Plonquet A, Lecron JC, Galactéros F, Bierling P. Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease. Haematologica 2007 92 : e132 e135.
14. D'Arena G, Califano C, Annunziata M, Tartarone A, Capalbo S, Villani O, Amendola G, Pietrantuono G, Ferrara F, Pinto A, Musto P, D'Arco AM, Cascavilla N. Rituximab for warm-type idiopathic autoimmune hemolytic anemia: a retrospective study of 11 adult patients. Eur J Haematol 2007 79 : 53 8.
15. Grainger JD, Makar Y, McManus A, Wynn R. Refractory hyperhaemolysis in a patient with beta-thalassaemia major. Transfus Med 2001 11 : 55 7.